News

News
Partner news

Aquinox Pharmaceuticals Commences Phase 2 Clinical Trial of AQX-1125 in Chronic Obstructive Pulmonary Disease

Read full story
Partner news

Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

Read full story
JNJ Press releases

Johnson & Johnson Innovation Establishes Network of Partnering Offices in UK Life Sciences Clusters

Read full story
Partner news

Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate GEN-004 to Prevent Infections Caused By Pneumococcus

Read full story
Partner news

CVRx® & DaVita Announce Strategic Partnership

Read full story
Partner news

CVRx® Closes $12 Million Additional Financing

Read full story
Partner news

ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine

Read full story
Partner news

Catalyst Biosciences and ISU Abxis Announce Collaboration to Develop Next-Generation Best-In-Class Factor IX Therapeutics

Read full story
Partner news

USGI Medical Receives FDA Approval to Launch Head-to-Head Pivotal Study to Determine Safety, Effectiveness of Incisionless, Endoscopic Weight Loss Procedure

Read full story
JNJ Press releases

Johnson & Johnson Innovation Celebrates Life Science Innovation

Read full story
Partner news

Merus Secures €31 Million in Series B Round Extension

Read full story
Partner news

Celladon Corporation Announces Publication of Long Term Follow-Up Results from the MYDICAR CUPID 1 Trial in Advanced Heart Failure

Read full story
Partner news

Protagonist Therapeutics Expands Series B Financing to $18 Million with Addition of $4 Million from Pharmstandard

Read full story
Partner news

Five Prime Therapeutics Announces Pricing of Initial Public Offering

Read full story